SCF (KITLG) (C-term), 244-273 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SCF (KITLG) (C-term), 244-273 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SCF (KITLG) (C-term), 244-273 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human (predicted reactivity: bovine, porcine) |
| Isotype | n/a |
| Format | purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 2 |
| Applications | Western Blot (WB), ELISA (EIA), Immunofluorescence (IF), Flow Cytometry (FC/FACS) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This SCF (KITLG) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 244-273 amino acids from the C-terminal region of human SCF (KITLG). KITLG is the ligand of the tyrosine-kinase receptor encoded by the KIT locus. This ligand is a pleiotropic factor that acts in utero in germ cell and neural cell development, and hematopoiesis, all believed to reflect a role in cell migration. In adults, it functions pleiotropically, while mostly noted for its continued requirement in hematopoiesis. |
| Immunogen | n/a |
| Other Names | [Kit ligand; Mast cell growth factor; MGF; Stem cell factor; SCF; c-Kit ligand; Soluble KIT ligand; sKITLG; KITLG; MGF; SCF] |
| Gene, Accession # | [KITLG], Gene ID: 4254, NCBI: NP_000890.1, UniProt: P21583 |
| Catalog # | MBS9203137 |
| Price | $165, $370 |
| Order / More Info | SCF (KITLG) (C-term), 244-273 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Young,S.M., Cell. Signal. 19 (12), 2572-2581 (2007) Pick,M., Stem Cells 25 (9), 2206-2214 (2007) Yasuda,A., Dig. Dis. Sci. 52 (9), 2292-2300 (2007) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies